Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ECEMX | 14.85 | 0.07 | +0.47% |
| Parametric Emerging Markets C | |||
| PMDIX | 17.73 | 0.04 | +0.23% |
| Principal Small-MidCap Dividend Inc Inst | |||
| IHSAX | 18.37 | 0.02 | +0.11% |
| Hartford Small Company A | |||
| CLTIX | 14.98 | -0.06 | -0.40% |
| Catalyst/Lyons Tactical Allocation I | |||
| SHSKX | 64.59 | -0.71 | -1.09% |
| BlackRock Health Sciences Opps K | |||
A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with CGEN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then CGEN could also see price increases.
| Ticker / NAME | Correlation To ASPHF | 1D Price Change % | ||
|---|---|---|---|---|
| ASPHF | 100% | N/A | ||
| CGEN - ASPHF | 41% Loosely correlated | -2.33% | ||
| CLLS - ASPHF | 34% Loosely correlated | +3.27% | ||
| CMVLF - ASPHF | 34% Loosely correlated | N/A | ||
| NURPF - ASPHF | 30% Poorly correlated | N/A | ||
| ALDX - ASPHF | 27% Poorly correlated | +0.93% | ||
More | ||||